Interactions of phytoestrogens with estrogen receptors α and β (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 2, 2004, Pages 185-188

  Kinjo, Junei ^a   Tsuchihashi, Ryota ^b   Morito, Keiko ^c   Hirose, Toshiharu ^c   Aomori, Tohru ^c   Nagao, Tsuneatsu ^a   Okabe, Hikaru ^a   Nohara, Toshihiro ^b   Masamune, Yukito ^c  

^a FUKUOKA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

hER binding; hER dependent galactosidase induction; hER dependent MCF 7 cell growth; Human estrogen receptor (hER); Isoflavone metabolite; Phytoestrogen

Indexed keywords

BETA GALACTOSIDASE; DAIDZEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; GLUCURONIDE; GLYCITEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ARTICLE; CELL GROWTH; CELL STIMULATION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME INDUCTION; ESTROGEN ACTIVITY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; SOYBEAN; URINALYSIS; BINDING COMPETITION; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECT; METABOLISM; TUMOR CELL LINE; URINE;

BETA-GALACTOSIDASE; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INDUCTION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; ISOFLAVONES; PHYTOESTROGENS; SOY FOODS;

EID: 14344264789     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.185     Document Type: Article

References (17)

1. Mäkelä S., Poutamen M., Kostian M. L., Lehtimäki N., Strauss L., Santti L., Vihko R., Proc. Soc. Exp. Biol. Med., 217, 310-316 (1998).
2. Green S., Water P., Greene G., Krust A., Goffin C., Jensen E., Scrace G., Waterfield M., Chambon P., J. Steroid Biochem., 24, 77-83 (1986).
3. Mosselman S., Polman J., Djikema R., FEBS Lett., 392, 49-53 (1996).
4. Nuclear Receptors Nomenclature Committee, Cell, 97, 161-163 (1999).
5. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., Ogawa S., Inoue S., Muramatsu M., Masamune Y., Biol. Pharm. Bull., 24, 351-356 (2001).
6. Morito K., Aomori T., Hirose T., Kinjo J., Hasegawa J., Ogawa S., Inoue S., Muramatsu M., Masamune Y., Biol. Pharm. Bull., 25, 48-52 (2002).
7. Yasuda T., Ueda J., Ohsawa K., Chem. Pharm. Bull., 49, 1495-1497 (2001).
8. Yasuda T., Ohsawa K., Biol. Pharm. Bull., 21, 953-957 (1998).
9. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S., Proc. Natl. Acad. Sci. U.S.A., 83, 2496-2500 (1986).
10. Lippman M. E., Bolan G., Nature (London), 256, 592-593 (1975).
11. Tsuchihashi R., Okawa M., Nohara T., Kinjo J., Abstracts of Papers 2, The 121st Annual Meeting of the Pharmaceutical Society of Japan, Sapporo, Mar. 2001, p. 116.
12. Wahara K., Salakka A., Adlercreutz H., Proc. Soc. Exp. Biol. Med., 217, 293-299 (1998).
13. Peterson T. G., Coward L., Kirk M., Falany C. N., Barnes S., Carcinogenesis, 17, 1861-1869 (1996).
14. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
15. Davis S. R., Dalais F. S., Simpson E. R., Murkies A. L., Recent. Prog. Horm. Res., 54, 185-211 (1999).
16. Bennetts H. W., Underwood E. J., Shier F. L., Aust. Ver. J., 22, 2-12 (1946).
17. Kurzer M. S., Xu X., Annu. Rev. Nutr. J., 17, 353-381 (1997).